In another study, the anti-metabolite 5-fluorouracil (5-FU) – which is used in the treatment of head, neck, breast and colorectal cancers – has been found to also induce the assembly of SGs by the phosphorylation of eIF2α (Kaehler et al., 2014). Here, EIF2A is linked to colorectal cancer.